Cynthia X Ma, M.D., Ph.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Cynthia X Ma, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06374459 · Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone MetastasisWashington University School of Medicine · recruiting · Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer · principal investigator
- Ph1NCT05791474 · ATI-2231 in Advanced Solid Tumor MalignanciesWashington University School of Medicine · withdrawn · Advanced Solid Tumor, Advanced Solid Tumor Malignancies · principal investigator
- Ph2NCT03007979 · Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast CancerWashington University School of Medicine · completed · Breast Cancer, Breast Carcinoma, Cancer of Breast · principal investigator
- Ph2NCT01723774 · PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerWashington University School of Medicine · active not recruiting · Breast Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.